首页 > 最新文献

Deutsche medizinische Wochenschrift (1946)最新文献

英文 中文
[Nephritic sediment - step by step]. [肾结石沉积物-一步一步]。
Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.1055/a-2325-4542
Cornelia Elisabeth Eckert, Dagmar Biegger, Jörg Latus, Fabian Alexander Riegg

The examination of urine and its evaluation are central components in the diagnostic pathway for kidney diseases. Essential to this process is the correct analysis and interpretation of the urine sediment. A nephritic sediment indicates glomerular kidney disease with high specificity. This article explains the diagnosis, evaluation, and implications of a nephritic sediment.

尿液检查及其评价是肾脏疾病诊断途径的核心组成部分。这个过程的关键是对尿液沉积物的正确分析和解释。肾小球沉淀物提示肾小球肾病,特异性高。这篇文章解释了肾结石沉积物的诊断、评估和影响。
{"title":"[Nephritic sediment - step by step].","authors":"Cornelia Elisabeth Eckert, Dagmar Biegger, Jörg Latus, Fabian Alexander Riegg","doi":"10.1055/a-2325-4542","DOIUrl":"https://doi.org/10.1055/a-2325-4542","url":null,"abstract":"<p><p>The examination of urine and its evaluation are central components in the diagnostic pathway for kidney diseases. Essential to this process is the correct analysis and interpretation of the urine sediment. A nephritic sediment indicates glomerular kidney disease with high specificity. This article explains the diagnosis, evaluation, and implications of a nephritic sediment.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 1-02","pages":"48-52"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Atypical spontaneous bacterial peritonitis linked to streptococcal toxic shock syndrome]. [与链球菌中毒性休克综合征有关的非典型自发性细菌性腹膜炎]。
Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.1055/a-2418-2842
Tomas Marin Cuartas, Ahmad Farid Nasri, Stefan Bollmann

Anamnesis and clinical examination: A 59-year-old female patient with an unremarkable medical history presented with watery diarrhea, severe lower abdominal pain, and fever for approximately 7 days. Physical examination revealed a distended abdomen, bowel sounds were absent, and there was an acute abdomen with generalized guarding and significantly elevated inflammatory markers.

Diagnosis: Abdominal computed tomography showed significant ascites and signs of peritonitis. Exploratory diagnostics were indicated. A laparoscopy was performed, which revealed diffuse purulent peritonitis. Organ perforation or other reasons for a peritonitis were excluded.

Therapy and clinical course: Bacteriological examination and blood cultures showed β-hemolytic group A streptococci, leading to the diagnosis of spontaneous bacterial peritonitis caused by streptococci. The patient was treated with antibiotics, progressively recovered, and was discharged symptom-free and without sequelae.

Conclusion: Primary spontaneous bacterial peritonitis caused by Streptococcus pyogenes is a rare cause of acute abdomen. An early diagnosis and immediate antibiotic therapy are crucial for prognosis.

回顾和临床检查:59岁女性患者,无明显病史,以水样腹泻,严重下腹痛,发热约7天。体格检查显示腹部膨胀,无肠音,急性腹部全身性保护,炎症标志物明显升高。诊断:腹部电脑断层显示明显腹水及腹膜炎征象。提示探索性诊断。行腹腔镜检查,发现弥漫性化脓性腹膜炎。排除器官穿孔或其他原因导致的腹膜炎。治疗及临床过程:细菌学检查及血培养示β-溶血性A组链球菌,诊断为链球菌所致自发性细菌性腹膜炎。患者经抗生素治疗,逐渐康复,出院时无症状,无后遗症。结论:由化脓性链球菌引起的原发性自发性细菌性腹膜炎是一种罕见的急腹症。早期诊断和立即抗生素治疗对预后至关重要。
{"title":"[Atypical spontaneous bacterial peritonitis linked to streptococcal toxic shock syndrome].","authors":"Tomas Marin Cuartas, Ahmad Farid Nasri, Stefan Bollmann","doi":"10.1055/a-2418-2842","DOIUrl":"https://doi.org/10.1055/a-2418-2842","url":null,"abstract":"<p><strong>Anamnesis and clinical examination: </strong>A 59-year-old female patient with an unremarkable medical history presented with watery diarrhea, severe lower abdominal pain, and fever for approximately 7 days. Physical examination revealed a distended abdomen, bowel sounds were absent, and there was an acute abdomen with generalized guarding and significantly elevated inflammatory markers.</p><p><strong>Diagnosis: </strong>Abdominal computed tomography showed significant ascites and signs of peritonitis. Exploratory diagnostics were indicated. A laparoscopy was performed, which revealed diffuse purulent peritonitis. Organ perforation or other reasons for a peritonitis were excluded.</p><p><strong>Therapy and clinical course: </strong>Bacteriological examination and blood cultures showed β-hemolytic group A streptococci, leading to the diagnosis of spontaneous bacterial peritonitis caused by streptococci. The patient was treated with antibiotics, progressively recovered, and was discharged symptom-free and without sequelae.</p><p><strong>Conclusion: </strong>Primary spontaneous bacterial peritonitis caused by <i>Streptococcus pyogenes</i> is a rare cause of acute abdomen. An early diagnosis and immediate antibiotic therapy are crucial for prognosis.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 1-02","pages":"44-47"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ethic dimensions of extracorporeal cardiopulmonary support systems]. [体外心肺支持系统的伦理问题]。
Pub Date : 2025-01-01 Epub Date: 2025-01-14 DOI: 10.1055/a-2363-3977
Jochen Dutzmann
{"title":"[Ethic dimensions of extracorporeal cardiopulmonary support systems].","authors":"Jochen Dutzmann","doi":"10.1055/a-2363-3977","DOIUrl":"https://doi.org/10.1055/a-2363-3977","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 3","pages":"106-109"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chronic Kidney Disease: epidemiology, implications for clinical practice and equations for diagnosis]. [慢性肾脏疾病:流行病学,对临床实践的影响和诊断方程]。
Pub Date : 2025-01-01 Epub Date: 2025-01-14 DOI: 10.1055/a-2265-9422
Elke Schaeffner

The article is based, among other things, on the updated KDIGO guideline for the evaluation and management of chronic kidney disease, which was published in Kidney International in March 2024. Chronic kidney disease is one of the most common chronic diseases, with a prevalence of around 10%, not least due to demographic ageing. The incidence of chronic kidney disease is approximately twice that of diabetes and approximately 20 times higher than that of cancer. Chronic kidney disease is classified using glomerular filtration rate and albuminuria. The definition of CKD may also include markers other than GFR and ACR. Patients with diabetes or hypertension should have GFR and ACR tested regularly. The individual risk of kidney failure requiring dialysis can be determined using a prediction equation. A better understanding of age- and gender-specific differences means that personalized therapy approaches are becoming increasingly important. Clinicians should be aware of the limitations of the endogenous biomarkers creatinine and cystatin C for determining GFR. For Germany, the equations of the European Kidney Function Consortium (EKFC) are recommended for estimating GFR.

该文章基于更新后的KDIGO慢性肾脏疾病评估和管理指南,该指南于2024年3月发表在《肾脏国际》杂志上。慢性肾病是最常见的慢性疾病之一,患病率约为10%,主要是由于人口老龄化。慢性肾脏疾病的发病率大约是糖尿病的两倍,是癌症的20倍。慢性肾脏疾病是用肾小球滤过率和蛋白尿来分类的。CKD的定义也可以包括GFR和ACR以外的标志物。糖尿病或高血压患者应定期检测GFR和ACR。需要透析的肾衰竭的个体风险可以用预测方程来确定。对年龄和性别差异的更好理解意味着个性化治疗方法正变得越来越重要。临床医生应该意识到内源性生物标志物肌酐和胱抑素C测定GFR的局限性。在德国,推荐使用欧洲肾功能联盟(EKFC)的公式来估算GFR。
{"title":"[Chronic Kidney Disease: epidemiology, implications for clinical practice and equations for diagnosis].","authors":"Elke Schaeffner","doi":"10.1055/a-2265-9422","DOIUrl":"https://doi.org/10.1055/a-2265-9422","url":null,"abstract":"<p><p>The article is based, among other things, on the updated KDIGO guideline for the evaluation and management of chronic kidney disease, which was published in Kidney International in March 2024. Chronic kidney disease is one of the most common chronic diseases, with a prevalence of around 10%, not least due to demographic ageing. The incidence of chronic kidney disease is approximately twice that of diabetes and approximately 20 times higher than that of cancer. Chronic kidney disease is classified using glomerular filtration rate and albuminuria. The definition of CKD may also include markers other than GFR and ACR. Patients with diabetes or hypertension should have GFR and ACR tested regularly. The individual risk of kidney failure requiring dialysis can be determined using a prediction equation. A better understanding of age- and gender-specific differences means that personalized therapy approaches are becoming increasingly important. Clinicians should be aware of the limitations of the endogenous biomarkers creatinine and cystatin C for determining GFR. For Germany, the equations of the European Kidney Function Consortium (EKFC) are recommended for estimating GFR.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 3","pages":"77-82"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of chronic kidney disease in IgA nephropathy]. [IgA肾病慢性肾病的治疗]。
Pub Date : 2025-01-01 Epub Date: 2025-01-14 DOI: 10.1055/a-2255-6329
Severin Schricker, Moritz Schanz, Jörg Latus

This article provides an overview of treatment approaches for chronic kidney disease (CKD) in patients with IgA nephropathy (IgAN). IgAN is the most common primary glomerulonephritis and results from an autoimmune reaction to aberrantly glycosylated immunoglobulin A (IgA) antibodies. Although historically considered largely benign, it is now recognized that a significant percentage of patients develop dialysis-dependent kidney disease over the years. Traditional treatments with RAAS inhibitors and newer therapies such as SGLT2 inhibitors, endothelin receptor antagonists, and delayed release, primarily locally acting enteric corticosteroids regarding their role in reducing proteinuria and preserving kidney function are also discussed. Additionally, non-immunosuppressive options and lifestyle modifications are examined for their potential to slow disease progression. Further promising medications are currently in clinical trials, including complement inhibitors and immunomodulators. These emerging therapies offer hope for significantly improving the prognosis of IgAN in the future. By presenting a comprehensive overview of current and potential future treatment strategies, this review aims to provide clinicians with up-to-date information to optimize the management of CKD in patients with IgAN.

本文概述了IgA肾病(IgAN)患者慢性肾脏疾病(CKD)的治疗方法。IgAN是最常见的原发性肾小球肾炎,由对异常糖基化免疫球蛋白A (IgA)抗体的自身免疫反应引起。虽然历史上认为大部分是良性的,但现在认识到,随着时间的推移,很大比例的患者会发展为透析依赖性肾脏疾病。传统的RAAS抑制剂治疗方法和新的治疗方法,如SGLT2抑制剂、内皮素受体拮抗剂和延迟释放,主要是局部作用的肠内皮质类固醇在减少蛋白尿和保持肾功能方面的作用也进行了讨论。此外,非免疫抑制选择和生活方式的改变被检查其减缓疾病进展的潜力。其他有希望的药物目前正在临床试验中,包括补体抑制剂和免疫调节剂。这些新兴疗法为将来显著改善IgAN的预后提供了希望。通过全面概述当前和潜在的未来治疗策略,本综述旨在为临床医生提供最新信息,以优化IgAN患者CKD的管理。
{"title":"[Treatment of chronic kidney disease in IgA nephropathy].","authors":"Severin Schricker, Moritz Schanz, Jörg Latus","doi":"10.1055/a-2255-6329","DOIUrl":"https://doi.org/10.1055/a-2255-6329","url":null,"abstract":"<p><p>This article provides an overview of treatment approaches for chronic kidney disease (CKD) in patients with IgA nephropathy (IgAN). IgAN is the most common primary glomerulonephritis and results from an autoimmune reaction to aberrantly glycosylated immunoglobulin A (IgA) antibodies. Although historically considered largely benign, it is now recognized that a significant percentage of patients develop dialysis-dependent kidney disease over the years. Traditional treatments with RAAS inhibitors and newer therapies such as SGLT2 inhibitors, endothelin receptor antagonists, and delayed release, primarily locally acting enteric corticosteroids regarding their role in reducing proteinuria and preserving kidney function are also discussed. Additionally, non-immunosuppressive options and lifestyle modifications are examined for their potential to slow disease progression. Further promising medications are currently in clinical trials, including complement inhibitors and immunomodulators. These emerging therapies offer hope for significantly improving the prognosis of IgAN in the future. By presenting a comprehensive overview of current and potential future treatment strategies, this review aims to provide clinicians with up-to-date information to optimize the management of CKD in patients with IgAN.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 3","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acutely Altered Mental Status: When the Patient is Acting Odd]. [急性精神状态改变:当病人行为怪异时]。
Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.1055/a-2360-0999
Zoi Netou-Kandylidou

An acutely altered mental status is a common presenting complaint. A wide variety of neurological, systemic or psychiatric conditions can be the cause. Sometimes there is even overlap of various diseases that contribute to the patient's confusion. The brain can be primarily or secondarily involved. A meticulous history and examination provide the first clues as to the origin of the alternation in personality. Most of the time further exams at the hospital are necessary to determine the diagnosis and plan the treatment. Nevertheless, even with just limited preclinical resources perceptive teams are able to gather and analyse enough information to diagnose and treat the patient. The result of this detective work can be quite rewarding, especially if the initial diagnosis is confirmed. Therapeutic measures preclinically focus on maintaining the cerebral equilibrium.

急性精神状态改变是常见的主诉。各种各样的神经系统、系统或精神疾病都可能是病因。有时甚至有各种疾病的重叠,导致患者的困惑。大脑可能主要或次要参与。细致的历史和检查提供了关于人格交替的起源的第一个线索。大多数情况下,在医院进行进一步的检查是必要的,以确定诊断和计划治疗。然而,即使只有有限的临床前资源,敏锐的团队也能够收集和分析足够的信息来诊断和治疗患者。这种检测工作的结果可能是相当有益的,特别是如果初步诊断得到证实。临床前的治疗措施侧重于维持大脑平衡。
{"title":"[Acutely Altered Mental Status: When the Patient is Acting Odd].","authors":"Zoi Netou-Kandylidou","doi":"10.1055/a-2360-0999","DOIUrl":"https://doi.org/10.1055/a-2360-0999","url":null,"abstract":"<p><p>An acutely altered mental status is a common presenting complaint. A wide variety of neurological, systemic or psychiatric conditions can be the cause. Sometimes there is even overlap of various diseases that contribute to the patient's confusion. The brain can be primarily or secondarily involved. A meticulous history and examination provide the first clues as to the origin of the alternation in personality. Most of the time further exams at the hospital are necessary to determine the diagnosis and plan the treatment. Nevertheless, even with just limited preclinical resources perceptive teams are able to gather and analyse enough information to diagnose and treat the patient. The result of this detective work can be quite rewarding, especially if the initial diagnosis is confirmed. Therapeutic measures preclinically focus on maintaining the cerebral equilibrium.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 1-02","pages":"53-63"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Deutsche Medizinische Wochenschrift - 150 years of nephrology in the DMW]. [德国医学杂志- 150年肾脏病在DMW]。
Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1055/a-2309-8315
Andreas Kribben, Elif Karakurt

Since its founding 150 years ago, the Deutsche Medizinische Wochenschrift has continually followed the developments in nephrology through countless publications. Pioneers in nephrology like Franz Volhard and Georg Haas were authors of the DMW, and new hypotheses, examination methods, and therapies were often debated here, as this article shows.

自150年前成立以来,德国医学协会通过无数出版物不断关注肾脏病学的发展。肾脏病学的先驱,如Franz Volhard和Georg Haas是DMW的作者,新的假设、检查方法和治疗方法经常在这里争论,正如本文所示。
{"title":"[Deutsche Medizinische Wochenschrift - 150 years of nephrology in the DMW].","authors":"Andreas Kribben, Elif Karakurt","doi":"10.1055/a-2309-8315","DOIUrl":"https://doi.org/10.1055/a-2309-8315","url":null,"abstract":"<p><p>Since its founding 150 years ago, the Deutsche Medizinische Wochenschrift has continually followed the developments in nephrology through countless publications. Pioneers in nephrology like Franz Volhard and Georg Haas were authors of the DMW, and new hypotheses, examination methods, and therapies were often debated here, as this article shows.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"149 24-25","pages":"1536-1545"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endocrinology, diabetology and metabolism in the 150 years of the DMW - A long and sustainable relationship]. [内分泌学,糖尿病学和新陈代谢在150年的DMW -一个长期和可持续的关系]。
Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1055/a-2339-0591
Hendrik Lehnert, Klaus Mann

The DMW is celebrating its 150th anniversary - and this period is precisely when endocrinology and diabetology evolved from the first experiments to molecular biology, genetic, and bioinformatics research. The DMW has always accompanied this process with numerous important publications, some of which are highlighted in this article.

DMW正在庆祝其成立150周年——这一时期正是内分泌学和糖尿病学从最初的实验发展到分子生物学、遗传学和生物信息学研究的时期。DMW一直伴随着这一进程,发表了许多重要的出版物,其中一些将在本文中重点介绍。
{"title":"[Endocrinology, diabetology and metabolism in the 150 years of the DMW - A long and sustainable relationship].","authors":"Hendrik Lehnert, Klaus Mann","doi":"10.1055/a-2339-0591","DOIUrl":"https://doi.org/10.1055/a-2339-0591","url":null,"abstract":"<p><p>The DMW is celebrating its 150th anniversary - and this period is precisely when endocrinology and diabetology evolved from the first experiments to molecular biology, genetic, and bioinformatics research. The DMW has always accompanied this process with numerous important publications, some of which are highlighted in this article.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"149 24-25","pages":"1492-1499"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Developments in intensive care medicine as reflected in the Deutsche Medizinische Wochenschrift]. [重症监护医学的发展反映在德国医学杂志上]。
Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1055/a-2291-2053
Matthias Kochanek, Uwe Janssens

The developments in intensive care medicine documented in the Deutsche Medizinische Wochenschrift over the decades have significantly improved survival rates in severe conditions and pushed the boundaries of what is possible in acute medicine. By analyzing past issues and articles, this article shows how the Deutsche Medizinische Wochenschrift has acted as a mirror of the dynamic landscape of intensive care medicine.

在过去的几十年里,重症监护医学的发展记录在德国医学杂志上,大大提高了重症患者的存活率,并推动了急性医学的发展。通过分析过去的问题和文章,本文展示了德国医学杂志如何成为重症监护医学动态景观的一面镜子。
{"title":"[Developments in intensive care medicine as reflected in the Deutsche Medizinische Wochenschrift].","authors":"Matthias Kochanek, Uwe Janssens","doi":"10.1055/a-2291-2053","DOIUrl":"https://doi.org/10.1055/a-2291-2053","url":null,"abstract":"<p><p>The developments in intensive care medicine documented in the Deutsche Medizinische Wochenschrift over the decades have significantly improved survival rates in severe conditions and pushed the boundaries of what is possible in acute medicine. By analyzing past issues and articles, this article shows how the Deutsche Medizinische Wochenschrift has acted as a mirror of the dynamic landscape of intensive care medicine.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"149 24-25","pages":"1514-1525"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[150 years of "remodeling" in internal medicine and cardiology as reflected in the DMW]. [在DMW中反映的内科和心脏病学150年的“重塑”]。
Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1055/a-2289-3859
Georg Ertl

This article reflects 150 years of medical progress, particularly in internal medicine and cardiology, which have been accompanied and documented by the Deutsche Medizinische Wochenschrift (DMW). A fascinating look back at the exciting development of this specialist field and an outlook on future possibilities.

这篇文章反映了150年来的医学进步,特别是在内科和心脏病学方面,这些都是由德国医学杂志(DMW)陪同和记录的。回顾这一专业领域令人兴奋的发展,并展望未来的可能性。
{"title":"[150 years of \"remodeling\" in internal medicine and cardiology as reflected in the DMW].","authors":"Georg Ertl","doi":"10.1055/a-2289-3859","DOIUrl":"https://doi.org/10.1055/a-2289-3859","url":null,"abstract":"<p><p>This article reflects 150 years of medical progress, particularly in internal medicine and cardiology, which have been accompanied and documented by the Deutsche Medizinische Wochenschrift (DMW). A fascinating look back at the exciting development of this specialist field and an outlook on future possibilities.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"149 24-25","pages":"1475-1480"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Deutsche medizinische Wochenschrift (1946)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1